Reader Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
- 26 May 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (10) , e210262
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Eculizumab in AQP4-IgG NMOSDNeurology, 2024
- Eculizumab Use in Neuromyelitis Optica Spectrum DisordersNeurology, 2024
- ECTRIMS 2024 – PosterMultiple Sclerosis Journal, 2024
- Patterns of neuromyelitis optica spectrum disorder attacks in different age groups and sexes depending on the status of immunosuppressive therapy: A retrospective cohort studyEuropean Journal of Neurology, 2023
- Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort studyJournal of Neuroinflammation, 2022